Validation of Software for Assessment of Sleep Apnea From Data Acquired by a Wearable Smartwatch

NCT ID: NCT03775291

Last Updated: 2022-08-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

303 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-11-09

Study Completion Date

2023-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This clinical validation study aims to evaluate the utility of Fitbit's Sleep Apnea Alert software for minimally invasive monitoring of sleep apnea events to alert users of their risk of sleep apnea. The Sleep Apnea Alert software analyses data from a Fitbit commercially available wrist photoplethysmogram (PPG) device. The Sleep Apnea Alert software is an investigational software as medical device (SaMD) and is designed to retrospectively process data and flag users who have physiological signals consistent with an apnea-hypopnea index (AHI) of 15 or greater. This clinical validation study will be used to validate Fitbit's PPG-based sleep apnea algorithm. The outputs of the Fitbit Sleep Apnea Alert software will not be available to study participants, as the scope of this study is to gather validation data only and does not include testing product usability components.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sleep Apnea

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Low pre-test likelihood for sleep apnea

Subjects at low risk for having sleep apnea due to lack of known risk factors and no complaints of symptoms related to sleep apnea (e.g., excessive daytime sleepiness)

Simultaneous assessment of sleep apnea by polysomnogram and wearable device

Intervention Type DIAGNOSTIC_TEST

Characterization of sleep apnea by lab-based polysomnogram

High pre-test likelihood for sleep apnea

Suspected sleep apnea patients who are undergoing sleep tests as part of normal medical care or are also known to be non-compliant with therapy.

Simultaneous assessment of sleep apnea by polysomnogram and wearable device

Intervention Type DIAGNOSTIC_TEST

Characterization of sleep apnea by lab-based polysomnogram

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Simultaneous assessment of sleep apnea by polysomnogram and wearable device

Characterization of sleep apnea by lab-based polysomnogram

Intervention Type DIAGNOSTIC_TEST

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Capable of giving informed consent
* Comfortable reading the provided written study instructions in English (and/or local language) and using a smartphone in English (and/or local language).
* Have medical insurance either in the form of private insurance or a national health program.

Exclusion Criteria

* No implanted cardiac devices
* Not pregnant. Pregnancy status will be confirmed per patient report of medical history, i.e., patients will be asked if they are pregnant or may be pregnant, and date of last menstrual cycle.
* No medical conditions which might lead to consistently low levels of perfusion in the vasculature at the wrist
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Fitbit LLC

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Conor Heneghan, PhD

Role: STUDY_DIRECTOR

Fitbit LLC

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Jasper Summit Research

Jasper, Alabama, United States

Site Status

Peninsula Sleep Center

Burlingame, California, United States

Site Status

Sleep Center Orange County

Irvine, California, United States

Site Status

Neurotrials Inc

Atlanta, Georgia, United States

Site Status

SleepMed Inc

Columbia, South Carolina, United States

Site Status

St Vincent's University Hospital

Dublin, , Ireland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Ireland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

129-0318-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.